Jernicalm Plus is a trusted combination formulation containing Trifluoperazine 5 mg and Trihexyphenidyl 2 mg tablets, developed for the effective management of schizophrenia, agitation, and psychotic disorders. Jernicalm Plus is widely prescribed to help control symptoms associated with dopamine imbalance while also reducing extrapyramidal side effects caused by antipsychotic therapy. Jernicalm Plus works through the dual action of Trifluoperazine, which helps manage psychotic symptoms by regulating dopamine receptors, and Trihexyphenidyl, which supports the prevention and treatment of drug-induced movement disorders. With this balanced formulation, Jernicalm Plus provides both symptom control and improved treatment tolerability. Healthcare professionals choose Jernicalm Plus for its reliable clinical performance, consistent quality manufacturing standards, and patient-focused therapeutic benefits. Jernicalm Plus is indicated for schizophrenia, behavioral disturbances, agitation, and related psychiatric conditions under proper medical supervision. When searching for Jernicalm Plus tablets, Jernicalm Plus 5 mg + 2 mg, or Jernicalm Plus antipsychotic tablets, this official Jernicalm Plus product page provides complete information regarding composition, indications, safety guidance, and distribution inquiries. Jernicalm Plus should be administered strictly as prescribed by a qualified healthcare professional. Dosage and duration of Jernicalm Plus treatment must be determined based on individual patient needs.